Patents by Inventor Christopher R. Conlee

Christopher R. Conlee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF
    Publication number: 20240165267
    Abstract: The present disclosure provides modified nucleosides, nucleotides, and nucleic acids, and methods of using them.
    Type: Application
    Filed: November 23, 2022
    Publication date: May 23, 2024
    Inventors: Atanu ROY, Christopher R. CONLEE, Antonin DE FOUGEROLLES, Andrew W. FRALEY
  • TRIAZOLE-CROSSLINKED AND THIOETHER-CROSSLINKED PEPTIDOMIMETIC MACROCYCLES
    Publication number: 20190292224
    Abstract: Provided herein are peptidomimetic macrocycles and methods of using such macrocycles for the treatment of disease.
    Type: Application
    Filed: January 30, 2019
    Publication date: September 26, 2019
    Inventors: Vincent Guerlavais, Christopher R. Conlee, Scott Paul Lentini
  • ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF
    Publication number: 20190255194
    Abstract: The present disclosure provides alternative nucleosides, nucleotides, and nucleic acids, and methods of using them.
    Type: Application
    Filed: March 1, 2019
    Publication date: August 22, 2019
    Inventors: Atanu ROY, Christopher R. CONLEE, Antonin DE FOUGEROLLES, Andrew W. FRALEY, Gabor BUTORA, Matthew STANTON
  • Alternative nucleic acid molecules and uses thereof
    Patent number: 10286086
    Abstract: The present disclosure provides alternative nucleosides, nucleotides, and nucleic acids, and methods of using them.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: May 14, 2019
    Assignee: ModernaTX, Inc.
    Inventors: Atanu Roy, Christopher R. Conlee, Antonin De Fougerolles, Andrew W. Fraley, Gabor Butora, Matthew Stanton
  • Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
    Patent number: 10227380
    Abstract: Provided herein are peptidomimetic macrocycles and methods of using such macrocycles for the treatment of disease.
    Type: Grant
    Filed: January 29, 2015
    Date of Patent: March 12, 2019
    Assignee: AILERON THERAPEUTICS, INC.
    Inventors: Vincent Guerlavais, Christopher R. Conlee, Scott Paul Lentini
  • ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF
    Publication number: 20170175129
    Abstract: The present disclosure provides alternative nucleosides, nucleotides, and nucleic acids, and methods of using them.
    Type: Application
    Filed: June 19, 2015
    Publication date: June 22, 2017
    Inventors: Atanu ROY, Christopher R. CONLEE, Antonin DE FOUGEROLLES, Andrew W. FRALEY
  • ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF
    Publication number: 20170136132
    Abstract: The present disclosure provides alternative nucleosides, nucleotides, and nucleic acids, and methods of using them.
    Type: Application
    Filed: June 19, 2015
    Publication date: May 18, 2017
    Applicant: Moderna Therapeutics, Inc.
    Inventors: Atanu ROY, Christopher R. CONLEE, Antonin DE FOUGEROLLES, Andrew W. FRALEY
  • ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF
    Publication number: 20170136131
    Abstract: The present disclosure provides alternative nucleosides, nucleotides, and nucleic acids, and methods of using them.
    Type: Application
    Filed: June 19, 2015
    Publication date: May 18, 2017
    Applicant: Modema Therapeutics, Inc.
    Inventors: Atanu ROY, Christopher R. CONLEE, Antonin DE FOUGEROLLES, Andrew W. FRALEY, Gabor BUTORA, Matthew STANTON
  • MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF
    Publication number: 20160354493
    Abstract: The present disclosure provides modified nucleosides, nucleotides, and nucleic acids, and methods of using them.
    Type: Application
    Filed: August 18, 2016
    Publication date: December 8, 2016
    Inventors: Atanu ROY, Christopher R. CONLEE, Antonin DE FOUGEROLLES, Andrew W. FRALEY
  • MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF
    Publication number: 20160354490
    Abstract: The present disclosure provides modified nucleosides, nucleotides, and nucleic acids, and methods of using them.
    Type: Application
    Filed: August 17, 2016
    Publication date: December 8, 2016
    Inventors: Atanu ROY, Christopher R. CONLEE, Antonin DE FOUGEROLLES, Andrew W. FRALEY
  • MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF
    Publication number: 20160354492
    Abstract: The present disclosure provides modified nucleosides, nucleotides, and nucleic acids, and methods of using them.
    Type: Application
    Filed: August 18, 2016
    Publication date: December 8, 2016
    Inventors: Atanu ROY, Christopher R. CONLEE, Antonin DE FOUGEROLLES, Andrew W. FRALEY
  • MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF
    Publication number: 20160354491
    Abstract: The present disclosure provides modified nucleosides, nucleotides, and nucleic acids, and methods of using them.
    Type: Application
    Filed: August 18, 2016
    Publication date: December 8, 2016
    Inventors: Atanu ROY, Christopher R. CONLEE, Antonin DE FOUGEROLLES, Andrew W. FRALEY
  • MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF
    Publication number: 20160348099
    Abstract: The present disclosure provides modified nucleosides, nucleotides, and nucleic acids, and methods of using them.
    Type: Application
    Filed: August 18, 2016
    Publication date: December 1, 2016
    Inventors: Atanu ROY, Christopher R. CONLEE, Antonin DE FOUGEROLLES, Andrew W. FRALEY
  • MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF
    Publication number: 20160304552
    Abstract: The present disclosure provides modified nucleosides, nucleotides, and nucleic acids, and methods of using them.
    Type: Application
    Filed: December 15, 2014
    Publication date: October 20, 2016
    Inventors: Atanu ROY, Christopher R. CONLEE, Antonin DE FOUGEROLLES, Andrew W. FRALEY, Ph.D.
  • POLYNUCLEOTIDE MOLECULES AND USES THEREOF
    Publication number: 20160264614
    Abstract: The present disclosure provides alternative nucleosides, nucleotides, and polynucleotides, and methods of use thereof.
    Type: Application
    Filed: October 2, 2014
    Publication date: September 15, 2016
    Applicant: MODERNA THERAPEUTICS, INC.
    Inventors: Christopher R. CONLEE, Andrew W. FRALEY, Atanu ROY
  • MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF
    Publication number: 20150307542
    Abstract: The present disclosure provides modified nucleosides, nucleotides, and nucleic acids, and methods of using them.
    Type: Application
    Filed: December 13, 2013
    Publication date: October 29, 2015
    Inventors: Atanu ROY, Christopher R. CONLEE, Antonin DE FOUGEROLLES, Andrew W. FRALEY
  • TRIAZOLE-CROSSLINKED AND THIOETHER-CROSSLINKED PEPTIDOMIMETIC MACROCYCLES
    Publication number: 20150183825
    Abstract: Provided herein are peptidomimetic macrocycles and methods of using such macrocycles for the treatment of disease.
    Type: Application
    Filed: January 29, 2015
    Publication date: July 2, 2015
    Inventors: Vincent GUERLAVAIS, Christopher R. CONLEE, Scott Paul LENTINI
  • ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF
    Publication number: 20150167017
    Abstract: The present disclosure provides alternative nucleosides, nucleotides, and nucleic acids, and methods of using them.
    Type: Application
    Filed: June 19, 2014
    Publication date: June 18, 2015
    Inventors: Atanu ROY, Christopher R. CONLEE, Antonin DE FOUGEROLLES, Andrew W. FRALEY
  • Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
    Patent number: 8987414
    Abstract: Provided herein are peptidomimetic macrocycles and methods of using such macrocycles for the treatment of disease.
    Type: Grant
    Filed: February 14, 2013
    Date of Patent: March 24, 2015
    Assignee: Aileron Therapeutics, Inc.
    Inventors: Vincent Guerlavais, Christopher R. Conlee, Scott Paul Lentini
  • Chemical compounds
    Patent number: 8222261
    Abstract: The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly Type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.
    Type: Grant
    Filed: January 13, 2009
    Date of Patent: July 17, 2012
    Assignee: GlaxoSmithKline, LLC
    Inventors: Subba R Katamreddy, Richard Dama Caldwell, Dennis Heyer, Vincente Samano, James Benjamin Thompson, Andrew J Carpenter, Christopher R Conlee, Eric Eugene Boros, Brian D Thompson